School of Medicine

The Latest

Campuswide Innovation at UC San Diego Gets $2.2 Million Boost from Elected Officials, UC System

Thanks to local and regional elected officials who helped assure passage of Assembly Bill 2664, the University of California San Diego has received $2.2 million from the UC system to help spur innovation and entrepreneurship on campus.

SDSC’s ‘Comet’ Supercomputer Surpasses ‘10,000 Users’ Milestone

Comet, the petascale supercomputer at the San Diego Supercomputer Center (SDSC), an Organized Research Unit of UC San Diego, has easily surpassed its target of serving at least 10,000 researchers across a diverse range of science disciplines, from astrophysics to redrawing the “tree of life”.

UC San Diego Researcher to Study Most Effective Treatment for Kawasaki Disease

Researchers at University of California San Diego School of Medicine, Rady Children’s Hospital-San Diego and Betty Irene Moore School of Nursing at University of California Davis have received a $2 million grant from the Patient-Centered Outcomes Research Institute (PCORI) for a three-year study to look at the effectiveness of two treatment options for children with KD who are resistant to initial therapy.

Potential New Drug Class Hits Multiple Cancer Cell Targets, Boosting Efficacy and Safety

In a new paper published this week in PNAS, researchers at the University of California San Diego School of Medicine and Moores Cancer Center, in collaboration with colleagues at Rady Children’s Hospital-San Diego, the University of Colorado School of Medicine and SignalRx, a San Diego-based biopharmaceutical company, describe a potential new class of anti-cancer drugs that inhibit two or more molecular targets at once, maximizing therapeutic efficiency and safety.

New Guidelines Promote More Family Engagement in Intensive Care Units

Having a loved one go through a critical illness is a stressful and traumatic experience that may have lasting effects months after the patient is discharged from the intensive care unit (ICU). To improve the well-being of both patients and family during this vulnerable time, a set of new guidelines has been released, providing physicians with evidence-based strategies to optimize outcomes for the critically ill and those at their bedside.

CIRM Approves New Funding to UC San Diego Researchers Fighting Zika Virus and Cancer

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.